| Buprenorphine Detoxification - BBDVI - 19 (NCT00000237) | National Institute on Drug Abuse (NIDA) | 1997-05-01 |
| Stress Hormones and Human Cocaine Use - 7 (NCT00000290) | National Institute on Drug Abuse (NIDA) | 1997-05-01 |
| Tyrosine for Methamphetamine Dependence - 1 (NCT00000322) | National Institute on Drug Abuse (NIDA) | 1997-04-01 |
| Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety (NCT00004373) | National Institute on Drug Abuse (NIDA) | 1997-03-01 |
| Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 (NCT00000274) | National Institute on Drug Abuse (NIDA) | 1997-03-01 |
| The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 (NCT00158288) | National Institute on Drug Abuse (NIDA) | 1997-03-01 |
| Tryptophan and Behavior Therapy for Cocaine Abuse - 1 (NCT00000324) | National Institute on Drug Abuse (NIDA) | 1997-03-01 |
| Modeling Impaired Judgement in Cocaine Abusers - 6 (NCT00015236) | National Institute on Drug Abuse (NIDA) | 1997-03-01 |
| Prepulse Inhibition of Startle in Cocaine Dependence - 7 (NCT00015249) | National Institute on Drug Abuse (NIDA) | 1997-02-01 |
| Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users (NCT00158236) | National Institute on Drug Abuse (NIDA) | 1997-01-01 |
| Cocaine Effects in Humans: Physiology and Behavior - 1 (NCT00000200) | National Institute on Drug Abuse (NIDA) | 1997-01-01 |
| Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1 (NCT00000352) | National Institute on Drug Abuse (NIDA) | 1996-12-01 |
| Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3 (NCT00000286) | National Institute on Drug Abuse (NIDA) | 1996-12-01 |
| Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 (NCT00015041) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1 (NCT00000315) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Buprenorphine and Naloxone Combination Study - 10 (NCT00015288) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 (NCT00015028) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Cocaine Abuse and ADHD - 10 (NCT00000275) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Methamphetamine Abuse Treatment in Patients With AIDS - 1 (NCT00000321) | National Institute on Drug Abuse (NIDA) | 1996-10-01 |
| Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 (NCT00000353) | National Institute on Drug Abuse (NIDA) | 1996-10-01 |
| Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2 (NCT00000316) | National Institute on Drug Abuse (NIDA) | 1996-08-01 |
| Evaluation of Liquid vs. Tablet Buprenorphine - 6 (NCT00000341) | National Institute on Drug Abuse (NIDA) | 1996-08-01 |
| Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence (NCT00134914) | National Institute on Drug Abuse (NIDA) | 1996-08-01 |
| Risperidone for the Treatment of Cocaine Dependence - 7 (NCT00000342) | National Institute on Drug Abuse (NIDA) | 1996-07-01 |
| Therapeutic Potential of Kappa-Opioids Against Cocaine - 1 (NCT00000323) | National Institute on Drug Abuse (NIDA) | 1996-07-01 |
| Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 (NCT00000354) | National Institute on Drug Abuse (NIDA) | 1996-07-01 |
| Pemoline in the Treatment of Stimulant Dependence - 5 (NCT00000340) | National Institute on Drug Abuse (NIDA) | 1996-06-01 |
| Infusion Laboratory: Protocol 3 (Risperidone) - 4 (NCT00000339) | National Institute on Drug Abuse (NIDA) | 1996-06-01 |
| Effects of Phenytoin on Cocaine Use in Humans - 2 (NCT00000285) | National Institute on Drug Abuse (NIDA) | 1996-05-01 |
| Brain Changes in Stimulant Dependent Subjects - 8 (NCT00000343) | National Institute on Drug Abuse (NIDA) | 1996-04-01 |
| Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 (NCT00000345) | National Institute on Drug Abuse (NIDA) | 1996-04-01 |
| Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 (NCT00015171) | National Institute on Drug Abuse (NIDA) | 1996-04-01 |
| Acute Withdrawal From Smoked Cocaine - 9 (NCT00000292) | National Institute on Drug Abuse (NIDA) | 1996-04-01 |
| Infusion Laboratory: Protocol 2 (Lisuride) - 3 (NCT00000338) | National Institute on Drug Abuse (NIDA) | 1996-03-01 |
| Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2 (NCT00000310) | National Institute on Drug Abuse (NIDA) | 1996-01-01 |
| Role of Metabolites in Nicotine Dependence (2) - 5 (NCT00000288) | National Institute on Drug Abuse (NIDA) | 1995-12-01 |
| Pergolide Treatment for Substance Abusers - 4 (NCT00000269) | National Institute on Drug Abuse (NIDA) | 1995-10-01 |
| Activity Monitoring Assessment of Opiate Withdrawal - 4 (NCT00000335) | National Institute on Drug Abuse (NIDA) | 1995-09-30 |
| Dextroamphetamine-Cocaine Behavioral Intervention - 5 (NCT00000308) | National Institute on Drug Abuse (NIDA) | 1995-09-01 |
| Buprenorphine Combination Tablet Feasibility - 1 (NCT00000298) | National Institute on Drug Abuse (NIDA) | 1995-08-01 |
| Naltrexone in Treatment of Cocaine Dependence - 5 (NCT00015080) | National Institute on Drug Abuse (NIDA) | 1995-05-01 |
| Cocaine Abuse and Attention Deficit Disorder - 3 (NCT00000268) | National Institute on Drug Abuse (NIDA) | 1995-05-01 |
| Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users (NCT00004740) | National Institute on Drug Abuse (NIDA) | 1995-02-01 |
| Relapse Patterns in Female Cocaine Users - 4 (NCT00000287) | National Institute on Drug Abuse (NIDA) | 1995-02-01 |
| Role of Metabolites in Nicotine Dependence (1) - 1 (NCT00000284) | National Institute on Drug Abuse (NIDA) | 1995-02-01 |
| Selegiline in Outpatient Treatment for Cocaine Dependence - 1 (NCT00000336) | National Institute on Drug Abuse (NIDA) | 1995-01-01 |
| Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 (NCT00000318) | National Institute on Drug Abuse (NIDA) | 1994-12-01 |
| Alternate-Day Buprenorphine Administration. Phase VII - 8 (NCT00000226) | National Institute on Drug Abuse (NIDA) | 1994-11-01 |
| Infusion Laboratory: Protocol 1 - Selegeline - 2 (NCT00000337) | National Institute on Drug Abuse (NIDA) | 1994-11-01 |
| Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 (NCT00000355) | National Institute on Drug Abuse (NIDA) | 1994-11-01 |
| M-CPP and Fenfluramine in Cocaine Addicts - 3 (NCT00000314) | National Institute on Drug Abuse (NIDA) | 1994-09-01 |
| Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 (NCT00000306) | National Institute on Drug Abuse (NIDA) | 1994-09-01 |
| Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 (NCT00000266) | National Institute on Drug Abuse (NIDA) | 1994-08-01 |
| Buprenorphine Detox With Two Types of Treatment. BBD I - 10 (NCT00000228) | National Institute on Drug Abuse (NIDA) | 1994-08-01 |
| Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1 (NCT00000245) | National Institute on Drug Abuse (NIDA) | 1994-05-01 |
| Flupenthixol Decanoate in Methamphetamine Smoking - 1 (NCT00000241) | National Institute on Drug Abuse (NIDA) | 1994-02-01 |
| Alternate-Day Buprenorphine Administration. Phase IV - 5 (NCT00000223) | National Institute on Drug Abuse (NIDA) | 1993-06-01 |
| Alternate Day Buprenorphine Administration, Phase X - 15 (NCT00000233) | National Institute on Drug Abuse (NIDA) | 1993-05-01 |
| Alternate-Day Buprenorphine. Phase V - 6 (NCT00000224) | National Institute on Drug Abuse (NIDA) | 1993-02-01 |
| Alternate-Day Buprenorphine Administration. Phase VI - 7 (NCT00000225) | National Institute on Drug Abuse (NIDA) | 1992-12-01 |
| Buprenorphine Dosing Interval - 5 (NCT00000209) | National Institute on Drug Abuse (NIDA) | 1992-11-01 |
| The Genetic Basis for Vulnerability to Substance Abuse (NCT00247819) | National Institute on Drug Abuse (NIDA) | 1992-08-01 |
| Alternate-Day Buprenorphine Administration. Phase II - 4 (NCT00000222) | National Institute on Drug Abuse (NIDA) | 1992-07-01 |
| Buprenorphine Maintenance for Opiate Dependence - 6 (NCT00000357) | National Institute on Drug Abuse (NIDA) | 1992-06-01 |
| Alternate-Day Buprenorphine Administration. Phase I - 3 (NCT00000221) | National Institute on Drug Abuse (NIDA) | 1992-04-01 |
| Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13 (NCT00000231) | National Institute on Drug Abuse (NIDA) | 1992-02-01 |
| Methadone/Buprenorphine Cross-Over Study - 4 (NCT00000208) | National Institute on Drug Abuse (NIDA) | 1992-02-01 |
| Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5 (NCT00000356) | National Institute on Drug Abuse (NIDA) | 1991-06-01 |
| Gradual Vs. Rapid Buprenorphine Detoxification - 2 (NCT00000220) | National Institute on Drug Abuse (NIDA) | 1991-06-01 |
| Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 (NCT00000211) | National Institute on Drug Abuse (NIDA) | 1989-09-01 |
| Treatment Efficacy for Drug Abuse and AIDS Prevention - 1 (NCT00000210) | National Institute on Drug Abuse (NIDA) | 1989-09-01 |
| Propranolol for Treatment of Cocaine Addiction - 2 (NCT00000197) | National Institute on Drug Abuse (NIDA) | 1987-01-01 |
| Psychostimulant Abuse - Novel Treatment Approaches - 1 (NCT00000325) | National Institute on Drug Abuse (NIDA) | |
| Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 (NCT00000358) | National Institute on Drug Abuse (NIDA) | |
| Pharmacotherapy and Intensive Treatment - 2 (NCT00000218) | National Institute on Drug Abuse (NIDA) | |
| Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 (NCT00000348) | National Institute on Drug Abuse (NIDA) | |
| Risperidone Treatment in Dually-Diagnosed Individuals - 2 (NCT00000267) | National Institute on Drug Abuse (NIDA) | |
| Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9 (NCT00015275) | National Institute on Drug Abuse (NIDA) | |
| Cognitive Correlates of Substance Abuse, Part 2 - 16 (NCT00000351) | National Institute on Drug Abuse (NIDA) | |
| Predictive Values of Serotonergic Alterations for Outcome - 2 (NCT00000313) | National Institute on Drug Abuse (NIDA) | |
| Buprenorphine Pharmacology Related to Addiction Treatment - 21 (NCT00000239) | National Institute on Drug Abuse (NIDA) | |
| Pharmacological Modulation of Cocaine Effects - 1 (NCT00000201) | National Institute on Drug Abuse (NIDA) | |
| Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1 (NCT00218140) | National Institute on Drug Abuse (NIDA) | |
| Buprenorphine Pharmacology Related to Addiction Treatment - 18 (NCT00000236) | National Institute on Drug Abuse (NIDA) | |
| Ph1 Lobeline Interaction Study - 1 (NCT00439504) | National Institute on Drug Abuse (NIDA) | |
| Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 (NCT00000344) | National Institute on Drug Abuse (NIDA) | |
| Alterations in Serotonergic Functions in Cocaine Addicts - 1 (NCT00000312) | National Institute on Drug Abuse (NIDA) | |
| IV Cocaine Abuse: A Laboratory Model - 4 (NCT00000215) | National Institute on Drug Abuse (NIDA) | |
| Study Comparing Liquid and Tablet Buprenorphine Formulations - 5 (NCT00000302) | National Institute on Drug Abuse (NIDA) | |
| Early Tobacco Abstinence - 5 (NCT00224965) | National Institute on Drug Abuse (NIDA) | |
| Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 (NCT00000349) | National Institute on Drug Abuse (NIDA) | |
| Cognitive Correlates of Substance Abuse - 11 (NCT00000346) | National Institute on Drug Abuse (NIDA) | |
| Alternate Day Buprenorphine Administration, Phase XII - 17 (NCT00000235) | National Institute on Drug Abuse (NIDA) | |